Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients
Cureus | Genetic Polymorphisms as Predictors of Survival in Breast Cancer: Future Lessons in Historical Data | Article
The Prediction of Survival in Hepatocellular Carcinoma Based on A Four Long Non-coding RNAs Expression Signature
View Image
Clinical outcomes in primary scalp angiosarcoma Corrigendum in /10.3892/ol.2020.12025
Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology
Postoperative Survival in Colitis-associated Colorectal Cancer With Ulcerative Colitis in Japan: A Multicenter Analysis | Anticancer Research
Postoperative Survival in Colitis-associated Colorectal Cancer With Ulcerative Colitis in Japan: A Multicenter Analysis | Anticancer Research
Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study | PLOS ONE
Differences in and verification of genetic alterations in chemotherapy and immunotherapy for metastatic melanoma | Aging
The main contributor to the upswing of survival in locally advanced colorectal cancer: an analysis of the SEER database - Yuqiang Li, Lilan Zhao, Cenap Güngör, Fengbo Tan, Zhongyi Zhou, Chenglong Li,
Ten-year review of survival and management of malignant glioma in Hong Kong | HKMJ
Cancers | Free Full-Text | Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single ...